Assembly Biosciences, Inc.

ASMB ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $82.0M $28.6M $27.1M $29.1M $27.1M $20.5M $37.0M $14.6M
Accounts Receivable $2.3M $0
Inventory
Total Current Assets $123.1M $53.6M $68.4M $29.2M $27.1M $20.5M $37.0M $14.6M
Property, Plant & Equipment $860.0K $214.7K $148.6K $156.4K $7.1K $6.8K $8.2K
Goodwill $12.6M $12.6M $12.6M $12.7M $0
Intangible Assets (Excl. Goodwill) $29.0M $29.0M $29.0M $29.0M $0
Total Assets $169.3M $98.1M $133.7M $71.2M $27.1M $20.6M $37.0M $14.6M
Liabilities
Accounts Payable $2.6M $1.8M $2.3M $312.9K
Total Current Liabilities $13.5M $7.1M $3.4M $1.1M $2.6M $2.5M $1.7M
Long-Term Debt
Total Liabilities $56.2M $18.2M $15.0M $12.7M $2.6M $2.7M $2.5M $3.0M
Stockholders' Equity
Retained Earnings $-251.0M $-208.2M $-164.0M $-135.5M $-111.7M
Total Stockholders' Equity $113.1M $79.9M $118.7M $58.6M $24.5M $17.8M $34.5M $11.6M
← Newer Page 2 of 2 Older →